DEUTSCHE BANK AG\ - UNITED THERAPEUTICS CORP DEL ownership

UNITED THERAPEUTICS CORP DEL's ticker is and the CUSIP is 91307CAF9. A total of 14 filers reported holding UNITED THERAPEUTICS CORP DEL in Q1 2015. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of UNITED THERAPEUTICS CORP DEL
ValueSharesWeighting
Q1 2015$3,375,000
-68.3%
937,000
-76.2%
0.00%
-71.4%
Q4 2014$10,653,000
-3.6%
3,937,000
-4.1%
0.01%0.0%
Q3 2014$11,049,000
-21.3%
4,107,000
-44.9%
0.01%
-30.0%
Q2 2014$14,042,000
+106.9%
7,457,000
+118.1%
0.01%
+100.0%
Q1 2014$6,786,000
-4.6%
3,419,000
+14.0%
0.01%0.0%
Q4 2013$7,116,000
+39.8%
3,000,0000.0%0.01%
+25.0%
Q3 2013$5,091,0003,000,0000.00%
Other shareholders
UNITED THERAPEUTICS CORP DEL shareholders Q1 2015
NameSharesValueWeighting ↓
Sage Capital Management, LLC 2,500,000$4,245,0004.05%
WHITEBOX ADVISORS LLC 34,365,000$58,350,0003.08%
BASSO CAPITAL MANAGEMENT, L.P. 10,000,000$16,963,0002.96%
CAMDEN ASSET MANAGEMENT L P /CA 21,257,000$36,084,0002.17%
GRACE BROTHERS MANAGEMENT LLC 1,500,000$2,549,0002.17%
Ferox Capital Management LP 3,000,000$5,101,0001.96%
Castle Creek Arbitrage, LLC 20,700,000$35,185,0001.57%
Polar Asset Management Partners Inc. 20,000,000$34,012,0001.44%
SYMPHONY ASSET MANAGEMENT LLC 7,712,000$13,091,0001.33%
Verition Fund Management LLC 2,500,000$4,256,0000.64%
View complete list of UNITED THERAPEUTICS CORP DEL shareholders